Search / Trial NCT06235320

Paracetamol Effect on Prostaglandins and Blood Pressure

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jan 30, 2024

Trial Information

Current as of October 08, 2024

Not yet recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Headache and orosurgical patients treated at the respective charite outpatient clinic.
  • * Age 18 years or older
  • * Able to consent
  • * Patients with migraine type headache treated with paracetamol or ibuprofen within the last 12 hours or not treated with paracetamol or ibuprofen within the last 48 hours
  • * Patients treated with with paracetamol or ibuprofen undergoing orosurgery for wisedome tooth extraction
  • Exclusion Criteria:
  • * Pregnancy
  • * Arterial hypertension
  • * Use of beta blockers
  • * Use of COX inhibitors other than paracetamol or ibuprofen, including low-dose acetylsalicylic acid
  • * Stable prophylactic therapy of migraine for less than 3 weeks
  • * Use of tryptans in the last two days (Frovatriptane in the last 6 days)
  • * Oral surgery patients using paracetamol or ibuprofen in the last 24 hours
  • * Known allergy to paracetamol or ibuprofen

About Charite University, Berlin, Germany

Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0